story of the week
Thromboprophylaxis After Hospitalization for COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial
Lancet 2021 Dec 15;[EPub Ahead of Print], E Ramacciotti, L Barile Agati, D Calderaro, VCR Aguiar, AC Spyropoulos, CCC de Oliveira, J Lins Dos Santos, GG Volpiani, ML Sobreira, EE Joviliano, MS Bohatch Júnior, BAL da Fonseca, MS Ribeiro, C Dusilek, K Itinose, SMV Sanches, K de Almeida Araujo Ramos, NF de Moraes, PFGMM Tierno, ALML de Oliveira, A Tachibana, RC Chate, MVB Santos, BB de Menezes Cavalcante, RCR Moreira, C Chang, A Tafur, J Fareed, RD LopesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.